PERRIGO Co plc (PRGO) Stock

HealthcareDrug Manufacturers - Specialty & Generic Website

6 members of Congress disclosed 11 trades in PRGO since 2014: 9 purchases and 2 sales, most recently Susan M Collins (purchase, Dec 30, 2016).

Which members of Congress traded PERRIGO Co plc (PRGO)?

Members
6
Disclosed trades
11
Purchases
9
Sales
2

Most recent: Susan M Collins (purchase, Dec 30, 2016); records start Feb 28, 2014.

PoliticianTrade dateTypeAmount
Susan Collins
R-ME · Senate
2016-12-30purchase$15k – $50k
Richard Hanna
R-NY · House
2016-08-24purchase$1k – $15k
Jim Inhofe
R-OK · Senate
2016-08-12sale$50k – $100k
Richard Hanna
R-NY · House
2016-07-20purchase$50k – $100k
Richard Hanna
R-NY · House
2016-06-07purchase$15k – $50k
Jim Inhofe
R-OK · Senate
2016-05-23purchase$50k – $100k
Richard Hanna
R-NY · House
2016-04-26purchase$100k – $250k
Alan Lowenthal
D-CA · House
2016-03-04purchase$1k – $15k

From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.

See all PRGO political trades →

PRGO price chart

Powered by TradingView

What does PERRIGO Co plc do?

Perrigo Company plc is a leading global provider in the pharmaceutical industry, primarily focused on manufacturing and distributing over-the-counter (OTC) consumer healthcare products. As a prominent player in the sector, Perrigo specializes in developing products that promote wellness and self-care, including vitamins, dietary supplements, and personal care items. Perrigo plays a crucial role in enhancing accessibility to health products by producing high-quality, affordable alternatives to brand-name drugs. This approach caters to a broad consumer base by providing options that are both effective and cost-efficient. Headquartered in Dublin, Ireland, Perrigo serves numerous markets across the world, impacting various industries by collaborating with healthcare institutions and retail channels. The company is recognized for its commitment to innovation and quality assurance, continuously adapting products to meet evolving consumer needs and regulatory standards. Perrigo's significant contributions to the pharmaceutical field underscore its importance in the global effort to improve public health and wellness through accessible and reliable healthcare solutions.

CEO
Mr. Patrick Lockwood-Taylor
Employees
8,100
Ask about PRGOAI research agent